Skip to main content
Top
Published in: Reproductive Health 1/2021

Open Access 01-12-2021 | Human Papillomavirus | Editorial

Refocusing on sexually transmitted infections (STIs) to improve reproductive health: a call to further action

Authors: Akaninyene Otu, Georges Danhoundo, Igor Toskin, Veloshnee Govender, Sanni Yaya

Published in: Reproductive Health | Issue 1/2021

Login to get access

Excerpt

STIs are infections that result from the transmission of a pathogenic organism by sexual contact [1]. Globally, STIs constitute a major burden and a significant public health challenge, driven by health systems challenges related to inadequately resourced, poor quality services on the one hand and social stigma and discrimination surrounding STIs on the other, which together discourage many people from seeking and receiving services (i.e. counselling, testing, and treatment) [2]. The World Health Organization (WHO) estimated that in 2016 the global annual incidence of four of the eight most prevalent STIs (i.e. chlamydia, gonorrhoea, trichomoniasis and syphilis) among people 15–49 years of age was 376.4 million infections [3]. These four infections are curable, unlike viral infections such as HIV, hepatitis B, herpes simplex virus (HSV) and human papillomavirus (HPV), requiring long term management and treatment. …
Literature
2.
go back to reference Starrs AM, Ezeh AC, Barker G, Basu A, Bertrand JT, Blum R, et al. Accelerate progress—sexual and reproductive health and rights for all: report of the Guttmacher-Lancet Commission. The Lancet. 2018;391(10140):2642–92.CrossRef Starrs AM, Ezeh AC, Barker G, Basu A, Bertrand JT, Blum R, et al. Accelerate progress—sexual and reproductive health and rights for all: report of the Guttmacher-Lancet Commission. The Lancet. 2018;391(10140):2642–92.CrossRef
15.
go back to reference Eisinger RW, Erbelding E, Fauci AS. Refocusing research on sexually transmitted infections. J Infect Dis. 2020;222:1432–4.CrossRefPubMed Eisinger RW, Erbelding E, Fauci AS. Refocusing research on sexually transmitted infections. J Infect Dis. 2020;222:1432–4.CrossRefPubMed
17.
go back to reference Web Annex 1. Key data at a glance. In: Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. Web Annex 1. Key data at a glance. In: Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
18.
go back to reference World Health Organization. Global health sector strategy on sexually transmitted infections 2016–2021. Geneva: World Health Organization; 2016. World Health Organization. Global health sector strategy on sexually transmitted infections 2016–2021. Geneva: World Health Organization; 2016.
21.
go back to reference Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. Guidelines for the management of symptomatic sexually transmitted infections. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
22.
go back to reference Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect. 2004;80:174–82.CrossRefPubMedPubMedCentral Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Transm Infect. 2004;80:174–82.CrossRefPubMedPubMedCentral
23.
go back to reference Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, et al. Cost-effectiveness of testing and treatment for hepatitis B virus and hepatitis C virus infections: an analysis by scenarios, regions, and income. Value Health. 2020;23(12):1552–60.CrossRefPubMedPubMedCentral Tordrup D, Hutin Y, Stenberg K, Lauer JA, Hutton DW, Toy M, et al. Cost-effectiveness of testing and treatment for hepatitis B virus and hepatitis C virus infections: an analysis by scenarios, regions, and income. Value Health. 2020;23(12):1552–60.CrossRefPubMedPubMedCentral
Metadata
Title
Refocusing on sexually transmitted infections (STIs) to improve reproductive health: a call to further action
Authors
Akaninyene Otu
Georges Danhoundo
Igor Toskin
Veloshnee Govender
Sanni Yaya
Publication date
01-12-2021

Other articles of this Issue 1/2021

Reproductive Health 1/2021 Go to the issue